PharmaResearch, led by CEO Jihoon Son, announced on the 29th that it successfully hosted the 2026 Art Symposium at Mayfield Hotel in Seoul on the 25th. This event serves as a critical platform for sharing clinical experiences and procedural strategies related to its aesthetic product line, particularly focusing on the flagship Rejuran series.

The symposium attracted approximately 170 medical professionals, fostering an environment where data-driven procedural approaches and the latest aesthetic trends were actively discussed. Presentations highlighted key offerings, including the Polynucleotide-based skin booster Rejuran, the clinic-exclusive Rejuran Synergy Booster, the hyaluronic acid filler Rejuviel, and the PLLA-based biostimulator Everwrinkle, underscoring the clinical efficacy of PharmaResearch’s integrated aesthetic portfolio.

Notably, this iteration of the symposium marked a departure from traditional lecture formats by enhancing panel discussion sessions. The theme of Intersection & Interaction facilitated an interactive academic exchange, allowing participants to share diverse clinical experiences and insights practically, thereby enriching the learning environment and promoting professional networking.

PharmaResearch plans to roll out additional symposiums in major cities across South Korea, including Yeosu, Busan, and Daejeon, as part of a broader strategy to strengthen ties with regional practitioners. This initiative aligns with its goal of expanding its clinical-based academic network nationwide, which is critical for enhancing brand presence and fostering community engagement in the medical aesthetic sector.

A spokesperson for PharmaResearch stated, “The Art Symposium acts as a core platform for sharing insights among medical practitioners based on clinical evidence. We aim to solidify our leadership position in the medical aesthetics field through ongoing academic activities and the advancement of our product portfolio.” This approach highlights the company's commitment to enhancing clinical competitiveness and establishing a strong foothold in the growing medical aesthetics market.

Furthermore, PharmaResearch manufactures and sells pharmaceuticals, medical devices, cosmetics, and health supplements based on regenerative medicine, utilizing materials such as DOT®PDRN and DOT®PN. Key products include Rejuran®, Rejuviel®, Conjuram®, Rejuran Cosmetics, Rian® eye drops, Rejuderma®, and Rejuviex Cream, all contributing to a robust and diversified product strategy aimed at capturing greater market share.